NeuroVista

Nottingham, United Kingdom Founded: 2002 • Age: 24 yrs
Online platform offering Toto Macau gambling registration and login.

About NeuroVista

NeuroVista was a Consumer company based in Nottingham (United Kingdom) founded in 2002 by Daniel DiLorenzo. It operates as an online platform offering Toto Macau gambling registration and login. It operates on a B2C model. NeuroVista has raised $61.3 million across 4 funding rounds from investors including Credit Suisse, Cyberonics and NIHI. The company is recorded as dissolved. NeuroVista offers products and services including Toto Macau Platform. Its focus areas include Entertainment, Online Gaming, Betting and Toto Macau. Its competitors include AliveCor, iHealth Labs, Aktiia, Monitra Healthcare and Agatsa and 4 more; 8 of its 9 listed competitors have raised funding.

Company details

UNGUTOTO serves as a digital site for Agen Bandar Toto Macau, enabling users to register and access trusted togel betting in 2025. It focuses on online gambling activities, integrating with cultural guides and events in Manchester. The platform provides secure login and betting options, primarily targeting individual users in the UK for entertainment and wagering. It connects to local listings but centers on digital betting services.

  • Headquarters Nottingham, United Kingdom
  • Founders Daniel DiLorenzo
  • Sectors
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website neurovista.com
  • Social X Facebook Instagram
Key Metrics
  • Total Equity Funding
    $61.3M (USD)

    in 4 rounds

  • Investors

Products & Services of NeuroVista

NeuroVista offers a comprehensive portfolio of products and services, including Toto Macau Platform.

Toto Macau Platform
Online Betting

Service for user registration and gambling on Toto Macau games

Funding Insights of NeuroVista

NeuroVista has successfully raised a total of $61.3M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $61.3M
  • Total Rounds 4
  • First Round $33.8M

    (May 2007)

  • Investors Count 9

All 4 funding rounds of NeuroVista with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2012–Series B–NIHI
–
Aug 2010$21.5MSeries B–GBS
Oct 2009$6MSeries B––
–
May 2007$33.8MSeries B–Advanced Technology Ventures, Delphi Ventures
Valuation history

9 investors in total: 9 institutional.

Investors in NeuroVista

NeuroVista has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Credit Suisse, Cyberonics and NIHI.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
VC firm making investment in early stage startups in the US
–atvcapital.comMenlo Park, United States
Investments are made in life sciences firms across all stages.
–delphiventures.comMenlo Park, United States
-
–gbsventures.com.au-
Early-stage tech startups are funded by this venture capital firm.
–flarecapital.comBoston, United States
Life science & tech focused VC firm investing in companies in the US
–threearchpartners.comSan Mateo, United States
NIHI provides education, research, and community building in health informatics.
2008nihi.caWaterloo, Canada
-
–snhproviders.org-
Vagus nerve stimulation therapy is developed for epilepsy and depression.
1987cyberonics.comHouston, United States
Wealth management, asset management, and investment banking services are offered.
1856credit-suisse.comZurich, Switzerland
Premium access

Investor details for NeuroVista

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of NeuroVista

1 people are tracked at NeuroVista (1 in leadership).

NameRoleGroup
Daniel DiLorenzo
FounderLeadership
Premium access

Complete people profiles for NeuroVista

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of NeuroVista

3 dated milestones of NeuroVista across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded NeuroVista is founded.
  2. Funding First funding round of $33.8M.
  3. Funding Latest funding round, Series B,.

Competitors of NeuroVista

NeuroVista has 9 listed competitors in our database, 8 of them funded. They include AliveCor, iHealth Labs, Aktiia, Monitra Healthcare and Agatsa, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
alivecor.com2010Mountain View, United States$114.38M67
Cardiac monitoring devices and applications are provided for heart health.
ihealthlabs.com2010Mountain View, United States$25M104
Personal healthcare devices for vital monitoring are designed and produced.
aktiia.com2018Neuchatel, Switzerland––
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
monitrahealth.com2016Hyderabad, India$3.68M41
Ambulatory cardiac monitoring devices and solutions
agatsa.com2014Noida, India$10.04M80
Portable ECG devices and heart health monitors are manufactured.
peerbridgehealth.com2012New York, United States$66.14M3
Wearable wireless ECG sensors for cardiac monitoring are developed.
preventicesolutions.com2004Valley, United States$137M–
Cloud-based remote telemonitoring platforms are supplied to healthcare providers.
profusa.com2009San Francisco, United States$62.16M15
Biochemical sensors are developed for real-time chronic disease monitoring.
vectoriousmedtech.com2011Tel Aviv, Israel$14.3M–
Miniature wireless implant for left atrial pressure monitoring is provided.
Premium access

Detailed competitors of NeuroVista

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Gambling & Entertainment Platforms

10 companies that operate in the same segment as NeuroVista (Gambling & Entertainment Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Licensed sports merchandise, collectibles, and betting platforms are provided.
2011New York, New York, United StatesUSD 4.85 B–14,656
Online skill-based games are developed across platforms and genres.
2010Delhi, Delhi, IndiaUSD 1.79 MUSD 166.95 M699
Mobile casino games with social features are developed for platforms.
2014Warsaw, PolandUSD 8.6 MUSD 246.28 M428
An online platform for skill-based gaming competitions is provided.
2019Gurugram, Haryana, IndiaUSD 25.96 MUSD 11.28 M39
Provider of online skill-based gaming platforms
2005Hyderabad, Telangana, IndiaUSD 81.87 MUSD 128.91 M529
Developer of a micro-betting platform for sports
2022Miami, Florida, United StatesUSD 102 M––
Provider of a P2P sports betting platform
2021New York, New York, United StatesUSD 75 M–94
Multi-category online gambling is facilitated via an app-based platform.
1934London, England, United Kingdom–USD 1.71 B10,239
Online platform for betting on multiple sports is provided.
2001Stoke On Trent, England, United Kingdom–––
Casual mobile games are developed and published by SciPlay.
2007London, England, United Kingdom–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Neurovista

Premium access

Complete news archive for NeuroVista

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NeuroVista

NeuroVista was founded in 2002 and raised its 1st funding round 5 years after it was founded.

NeuroVista is headquartered in Nottingham, United Kingdom.

NeuroVista is a funded company, having raised a total of $61.3M across 4 funding rounds to date. The company's 1st funding round was a Series B of $33.8M, raised on May 2007.

UNGUTOTO serves as a digital site for Agen Bandar Toto Macau, enabling users to register and access trusted togel betting in 2025. It focuses on online gambling activities, integrating with cultural guides and events in Manchester. The platform provides secure login and betting options, primarily targeting individual users in the UK for entertainment and wagering. It connects to local listings but centers on digital betting services.

NeuroVista's top competitors include AliveCor, iHealth Labs and Profusa.

NeuroVista offers Toto Macau Platform.

NeuroVista has 9 investors. Key investors include Credit Suisse, Cyberonics, NIHI, Advanced Technology Ventures, and Delphi Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available